$G

Genpact LTD (G): Results of Operations and Financial Condition

Genpact LTD (G) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 genpactltdexhibit991q226.htm EX-99.1 Document Exhibit 99.1 Genpact Reports Second Quarter 2026 Results Advanced Technology Solutions net revenue growth, up 24% year-over-year, drives Q2 performance NEW YORK, August 6, 2026 — Genpact Limited (NYSE: G), the Agentic Operat

Original reporting
Published Aug 6, 2026, 8:11 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 6, 2026, 8:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$G
Bullish
high confidence
Mentioned
$G
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$GBullishHigh
01

Why it matters

The key tradable items are the raised full-year adjusted diluted EPS growth guidance (at least 12% YoY) and the reiterated ATS growth target (at least 25% YoY), plus Q3 revenue and adjusted EPS ranges.

02

Market read

Investors get a fresh, quantified earnings and guidance package, including Q3 net revenue and adjusted EPS ranges and full-year margin and adjusted EPS growth targets.

03

What to watch

The guidance includes a Core Business Services outlook of flat to slightly down for Q3, so upside may be concentrated in ATS rather than broad-based growth.

Relevance 7/10Novelty 9/10Timing: after-hours guidance update from an SEC-filed Q2 results release

Background

This is Genpact’s SEC-filed 8-K with an earnings release (Item 2.02) covering Q2 2026 results and updated Q3 and full-year 2026 outlook.

Company-level read

Ticker impact

$GBullishHigh confidence
Context

Genpact reported Q2 net revenues of $1.343B (+7.1% YoY) and raised full-year adjusted diluted EPS growth to at least 12% for 2026.

Expected impact

Likely positive near-term bias for G, with follow-through dependent on whether Q3 revenue range and ATS growth at least 25% are met.

Evidence & confidence

The filing discloses multiple forward-looking datapoints: Q2 performance, Q3 revenue and EPS ranges, and full-year margin and adjusted EPS growth guidance, all tied to ATS growth of at least 25%.

Market effects

Reinforces demand strength for AI-enabled business process services, potentially improving sentiment for the broader agentic operations and IT services peer group.

Limited direct regional read-through; primarily US-listed services sentiment.

ATS growth and margin commentary may influence global outsourcing and AI services expectations, but impact is company-specific.

Counterpoint

Cash from operations fell to $72M versus $177M in Q2 2025, which could temper enthusiasm if investors focus on cash conversion.

Key entities

  • Genpact Limited

    Agentic Operations company reporting Q2 2026 results and raising 2026 adjusted EPS growth guidance.

  • Balkrishan "BK" Kalra

    CEO quoted emphasizing accelerating flywheel and faster pivot to Agentic Operations.

  • Michael Weiner

    CFO quoted highlighting record bookings, increasing backlog, and raised adjusted EPS guidance.

Related articles

$GMed

Deutsche Bank ranks IT Services stocks ahead of earnings By Investing.com

Deutsche Bank analyst Nate Svensson cut price targets across IT Services ahead of earnings, citing weaker enterprise demand into Q2 2026 from geopolitical uncertainty, higher rate expectations, and a softer macro backdrop. He flagged AI-driven productivity and disintermediation risks. Genpact PT $31, Accenture PT $136, Cognizant PT $55, EPAM PT $85, Globant PT $33.

$GMed

Why Genpact (G) Stock Is Up Today

Genpact (NYSE: G) shares rose about 2.7% after the company announced a partnership with Nestlé to set up a Global Capability Centre in Hyderabad, India. Genpact will support process intelligence, data, AI and automation to help Nestlé scale business services. The stock later traded around $29.72, up ~2.6% from the prior close.

$GMed

Why Genpact (G) Stock Is Up Today

Genpact (NYSE: G) shares rose about 3% after the company launched Genpact Deductions Recovery, an AI agent-powered platform for consumer goods firms to automate accounts receivable deduction management. Genpact said it can cut deduction cycle times up to 20%, raise annual recovery gains up to 15%, and reduce leakage ~1.5%.

$CVSAHigh

Covista Inc. (CVSA): Results of Operations and Financial Condition

Covista Inc. (CVSA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 cvsa-20260806xex99d1.htm EX-99.1 Exhibit 99.1 Investor Contact: Jeremy Cohen Investor.Relations@Covista.com +1 312-906-6600 ​ Media Contact: Maureen Bender CovistaMedia@Covista.com +1 313-319-4732 Covista Announces Fiscal Year 2026 Results, Exceeds Financial Guidance; I

$RGAMed

REINSURANCE GROUP OF AMERICA INC (RGA): Results of Operations and Financial Condition

REINSURANCE GROUP OF AMERICA INC (RGA) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 qfs2q26.htm EX-99.2 Document Exhibit 99.2 Quarterly Financial Supplement Second Quarter 2026 (Unaudited) World Headquarters Internet Address Contacts 16600 Swingley Ridge Road www.rgare.com Laura Cockrill Chesterfield, Missouri 63017 U.S.A. EVP, Chief Financial Officer

$PBYIMed

PUMA BIOTECHNOLOGY, INC. (PBYI): Results of Operations and Financial Condition

PUMA BIOTECHNOLOGY, INC. (PBYI) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_973970.htm EXHIBIT 99.1 ex_973970.htm Exhibit 99.1 News Release Puma Biotechnology Reports Second Quarter 2026 Financial Results Raising 2026 Revenue and Net Income Guidance Based on Increased Demand for NERLYNX LOS ANGELES, Calif., Aug. 6, 2026 - Puma Biotechnology,